Free Trial

Chinese court sentences a Japanese man to more than 3 years in prison on espionage charges

A cyclist rides past outside the Beijing No.2 Intermediate People's Court, March 31, 2022, in Beijing. (AP Photo/Ng Han Guan, File)

Key Points

  • A Japanese man in his 60s and employee of Astellas Pharma was sentenced to three and a half years in prison on charges of espionage after being detained in China since March 2023.
  • Japanese ambassador Kenji Kanasugi called the verdict “extremely regrettable,” demanding the detainee’s early release and urging China to ensure humane treatment and judicial transparency.
  • Chinese Foreign Ministry spokesperson Lin Jian asserted the case was handled strictly according to law and that foreign nationals in lawful employment “have nothing to worry about.”
  • Under China’s 2014 anti-spying law, 17 Japanese citizens have been detained, prompting safety warnings for visitors and heightening concerns in Japan’s business community.
  • Want stock alerts on Astellas Pharma? Get 5 Weeks of MarketBeat All Access for $5. Get My Stock Alerts.

BEIJING (AP) — A Japanese man was sentenced Wednesday to three and a half years in prison in China on espionage charges, according to the Japanese embassy in Beijing.

The embassy did not identify the man, who has been detained since March 2023. Japan's Kyodo News Agency described him as a man in his 60s and an employee of Astellas Pharma Inc., a major Japanese pharmaceutical company.

The man was charged with espionage in August and his first hearing was held in November but no details were released.

The Beijing No. 2 Intermediate People’s Court did not immediately make an announcement after handing down the sentence.

Kenji Kanasugi, the Japanese ambassador to China, called the sentencing “extremely regrettable." The Japanese government has protested a series of detentions of its citizens in China.

Chinese Foreign Ministry spokesperson Lin Jian said that judicial authorities had handled the case in strict accordance with the law and that China provides a sound environment for Japanese companies and workers.

"As long as foreign nationals in China abide by the law and engage in lawful employment, there is nothing to worry about,” he said.

A total of 17 Japanese citizens with business or other connections to China have been detained since 2014, when China enacted the anti-spying law. Five remain in China, Kyodo reported. A Japanese diplomat was detained for questioning in 2022 and released hours later, prompting strong protests from Japan.

Kanasugi was present at Wednesday's ruling, but Japanese reporters were not allowed inside the courtroom. He told reporters that Japan has demanded and will continue to demand the early release of detained Japanese nationals, adding that such detentions are “one of the biggest obstacles to improving people-to-people exchanges and public sentiment between Japan and China.”

A statement released by the Japanese embassy in Beijing urged the Chinese government to ensure the humane treatment of detainees and to improve the transparency of the judicial process.

Japan considers China's growing influence in the region as a threat to its national security and economy, and the risks of getting caught in China on espionage allegations are a growing concern in Japan, including its business community. A safety handbook for visitors to China, published by the Japanese embassy in Beijing, urges visitors to use extra caution.

___

Yamaguchi reported from Tokyo.

Should You Invest $1,000 in Astellas Pharma Right Now?

Before you consider Astellas Pharma, you'll want to hear this.

MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Astellas Pharma wasn't on the list.

While Astellas Pharma currently has a Hold rating among analysts, top-rated analysts believe these five stocks are better buys.

View The Five Stocks Here

Options Trading Made Easy - Download Now Cover

Learn the basics of options trading and how to use them to boost returns and manage risk with this free report from MarketBeat. Click the link below to get your free copy.

Get This Free Report
Like this article? Share it with a colleague.

Featured Articles and Offers

Recent Videos

Quantum Boom: 3 Strong Picks with Lower Risk
3 Overlooked AI Stocks That Chipmakers Can’t Live Without
Palantir & AMD Earnings: Massive Options Setups Ahead

Stock Lists

All Stock Lists

Investing Tools

Calendars and Tools

Search Headlines